27481922|t|Polymorphisms in Inflammatory Mediator Genes and Risk of Preeclampsia in Taiyuan, China
27481922|a|Excessive maternal inflammatory response is involved in the pathogenesis of preeclampsia. Few epidemiologic studies have investigated the associations between genetic variations in the inflammatory mediator genes and preeclampsia risk, and these studies have reached inconsistent results. We examined 31 single-nucleotide polymorphisms in IL-1A, IL-1B, IL-1R1, IL-2RA, IL-5RA, IL-6, IL-6R, TNFSF11, TNFRSF11A, IL-28RA, IRAK4, and KIT genes and the risk of preeclampsia and its clinical subtypes in a nested case-control study including 203 preeclampsia cases and 233 controls. We found that IL-1R1, IL-5RA, IL-6R, and TNFSF11 were associated with the risk of preeclampsia. Although the significant associations observed for preeclampsia overall were mainly seen for late-onset preeclampsia and severe preeclampsia, IL-6R (rs2229238) and TNFSF11 (rs9525643) polymorphisms were associated with the risk of early-onset preeclampsia. TNFSF11 (rs2200287 and rs2148072) polymorphisms were associated with risk of mild preeclampsia. Our study provided the first evidence that genetic variations in inflammatory mediator genes IL-1R1, IL-6R, TNFSF11, and IL-5RA were associated with preeclampsia risk, and the risk varied by preeclampsia subtypes.
27481922	0	13	Polymorphisms	T086	C0752046
27481922	17	29	Inflammatory	T169	C0333348
27481922	30	44	Mediator Genes	T028	C0017337
27481922	49	53	Risk	T078	C0035647
27481922	57	69	Preeclampsia	T046	C0032914
27481922	73	80	Taiyuan	UnknownType	C0681784
27481922	82	87	China	T083	C0008115
27481922	88	97	Excessive	T080	C0442802
27481922	98	106	maternal	T033	C1858460
27481922	107	128	inflammatory response	T046	C1155266
27481922	148	160	pathogenesis	T046	C0699748
27481922	164	176	preeclampsia	T046	C0032914
27481922	182	203	epidemiologic studies	T062	C0002783
27481922	209	221	investigated	T169	C1292732
27481922	226	238	associations	T080	C0439849
27481922	247	265	genetic variations	T070	C0042333
27481922	273	285	inflammatory	T169	C0333348
27481922	286	300	mediator genes	T028	C0017337
27481922	305	317	preeclampsia	T046	C0032914
27481922	318	322	risk	T078	C0035647
27481922	334	341	studies	T062	C0002783
27481922	392	423	single-nucleotide polymorphisms	T086	C0752046
27481922	427	432	IL-1A	T028	C1708430
27481922	434	439	IL-1B	T028	C1334112
27481922	441	447	IL-1R1	T116,T129,T192	C0391754
27481922	449	455	IL-2RA	T116,T129,T192	C1101536
27481922	457	463	IL-5RA	T116,T129,T192	C1704269
27481922	465	469	IL-6	T028	C1334122
27481922	471	476	IL-6R	T116,T129,T192	C0063717
27481922	478	485	TNFSF11	T028	C1367028
27481922	487	496	TNFRSF11A	T028	C1420805
27481922	498	505	IL-28RA	T028	C1425622
27481922	507	512	IRAK4	T028	C1334137
27481922	518	527	KIT genes	T028	C1416655
27481922	536	540	risk	T078	C0035647
27481922	544	556	preeclampsia	T046	C0032914
27481922	565	573	clinical	T080	C0205210
27481922	574	582	subtypes	T185	C0449560
27481922	588	613	nested case-control study	T062	C0027775
27481922	628	640	preeclampsia	T046	C0032914
27481922	641	646	cases	T077	C1706256
27481922	655	663	controls	T096	C0009932
27481922	679	685	IL-1R1	T116,T129,T192	C0391754
27481922	687	693	IL-5RA	T116,T129,T192	C1704269
27481922	695	700	IL-6R	T116,T129,T192	C0063717
27481922	706	713	TNFSF11	T028	C1367028
27481922	719	734	associated with	T080	C0332281
27481922	739	743	risk	T078	C0035647
27481922	747	759	preeclampsia	T046	C0032914
27481922	774	785	significant	T078	C0750502
27481922	786	798	associations	T080	C0439849
27481922	812	824	preeclampsia	T046	C0032914
27481922	825	832	overall	T080	C1561607
27481922	854	864	late-onset	T079	C4025592
27481922	865	877	preeclampsia	T046	C0032914
27481922	882	888	severe	T080	C0205082
27481922	889	901	preeclampsia	T046	C0032914
27481922	903	908	IL-6R	T116,T129,T192	C0063717
27481922	910	919	rs2229238	T170	C0282574
27481922	925	932	TNFSF11	T028	C1367028
27481922	934	943	rs9525643	T170	C0282574
27481922	945	958	polymorphisms	T086	C0752046
27481922	964	979	associated with	T080	C0332281
27481922	984	988	risk	T078	C0035647
27481922	1004	1016	preeclampsia	T046	C0032914
27481922	1018	1025	TNFSF11	T028	C1367028
27481922	1027	1036	rs2200287	T170	C0282574
27481922	1041	1050	rs2148072	T170	C0282574
27481922	1052	1065	polymorphisms	T086	C0752046
27481922	1071	1086	associated with	T080	C0332281
27481922	1087	1091	risk	T078	C0035647
27481922	1100	1112	preeclampsia	T046	C0032914
27481922	1118	1123	study	T062	C2603343
27481922	1143	1151	evidence	T078	C3887511
27481922	1157	1175	genetic variations	T070	C0042333
27481922	1179	1191	inflammatory	T169	C0333348
27481922	1192	1206	mediator genes	T028	C0017337
27481922	1207	1213	IL-1R1	T116,T129,T192	C0391754
27481922	1215	1220	IL-6R	T116,T129,T192	C0063717
27481922	1222	1229	TNFSF11	T028	C1367028
27481922	1235	1241	IL-5RA	T116,T129,T192	C1704269
27481922	1247	1262	associated with	T080	C0332281
27481922	1263	1275	preeclampsia	T046	C0032914
27481922	1276	1280	risk	T078	C0035647
27481922	1290	1294	risk	T078	C0035647
27481922	1305	1317	preeclampsia	T046	C0032914
27481922	1318	1326	subtypes	T185	C0449560